Anaveon AG
Pharmaceuticals · Basel, Basel-Stadt
Anaveon AG is a Swiss pharmaceuticals company based in Basel, Canton of Basel-Stadt, listed in the Swiss commercial register since 2017 (UID CHE-232.476.299).
Board members & signatories
- Dieter Weinand — Präsident des Verwaltungsrates
- Gonzalo Garcia Gajardo — Mitglied des Verwaltungsrates
- Denis Patrick — Mitglied des Verwaltungsrates
Registered purpose
Die Gesellschaft bezweckt die Erforschung, die Entwicklung, die Herstellung, die Verwertung, den Erwerb und den Vertrieb von pharmazeutischen und diagnostischen Produkten. Die Gesellschaft kann sich daneben an anderen Unternehmen irgendwelcher Art im In- und Ausland beteiligen, solche gründen, übernehmen und mit ihnen fusionieren. Sie kann Liegenschaften und Immaterialgüterrechte im In- und Auslan…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Anaveon does
OFFERING
Anaveon AG develops next-generation biologics aimed at selectively eliminating or reprogramming pathogenic immune cells involved in autoimmune diseases. Their primary product, ANV200, is a precision-engineered antibody designed for deep depletion of PD-1-expressing immune cells, which are implicated in driving harmful immune responses and inflammation. Currently, ANV200 is in preclinical development, with plans for clinical testing in the near future.
Unlock the full analysis →Similar companies
- Adagene AG — Pharmaceuticals · Basel
- Asceneuron AG — Pharmaceuticals · Eysins
- Arakena Pharmaceuticals AG — Pharmaceuticals · Basel
- CanVirex AG — Pharmaceuticals · Basel
- Ardanza Biopharma AG — Biotechnology · Zug
- Amyra Biotech AG — Pharmaceuticals · Basel
Find every pharmaceuticals company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned pharmaceuticals companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime